Showing 41 - 60 of 84 trials – Showing only trials currently accepting patients
-
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Stanford is currently accepting patients for this trial. -
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Stanford is currently accepting patients for this trial. -
Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Stanford is currently accepting patients for this trial. -
Neuroblastoma Biology Study
Stanford is currently accepting patients for this trial. -
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Stanford is currently accepting patients for this trial. -
Feasibility Neurocognitive Outcome After Transplant
Stanford is currently accepting patients for this trial. -
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
Stanford is currently accepting patients for this trial. -
ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma
Stanford is currently accepting patients for this trial. -
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
Stanford is currently accepting patients for this trial. -
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Stanford is currently accepting patients for this trial. -
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Stanford is currently accepting patients for this trial. -
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas(DIPG) & Spinal Diffuse Midline Glioma(DMG)
Stanford is currently accepting patients for this trial. -
CTL019 Out of Specification MAP for ALL or DLBCL Patients
Stanford is currently accepting patients for this trial. -
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Stanford is currently accepting patients for this trial. -
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
Stanford is currently accepting patients for this trial. -
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Stanford is currently accepting patients for this trial. -
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Stanford is currently accepting patients for this trial. -
CIBMTR Research Database
Stanford is currently accepting patients for this trial. -
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Stanford is currently accepting patients for this trial. -
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
Stanford is currently accepting patients for this trial.